Introduced to medical institutions nationwide approximately one year after launch. Japan's first "completely disposable" patch-type electrocardiograph receives commendation from the Furukawa Medical and Welfare Equipment Promotion Foundation.
Kokoromil Co., Ltd.'s "eclat," Japan's first completely disposable, 7-day continuous monitoring patch-type Holter electrocardiograph, has received a commendation in the social activity field from the Furukawa Medical and Welfare Equipment Promotion Foundation. The award recognizes "eclat" for its significant contributions to labor-saving in healthcare and reducing patient burden, addressing urgent issues like healthcare professional shortages and work style reforms in Japan. The device's rapid adoption and innovative features, such as its cordless design and mail-in return system, have been highly praised.
📋 Article Processing Timeline
- 📰 Published: April 15, 2026 at 22:05
- 🔍 Collected: April 15, 2026 at 13:31
- 🤖 AI Analyzed: April 15, 2026 at 19:07 (5h 35m after Collected)
Kokoromil Co., Ltd. (Headquarters: Shinjuku-ku, Tokyo; Representative Director: Daiki Hayashi), which developed Japan's first completely disposable, 7-day continuous monitoring patch-type Holter electrocardiograph "eclat," has been selected as a recipient of the commendation in the social activity field at the "13th Commendation and Research Grant" hosted by the Furukawa Medical and Welfare Equipment Promotion Foundation.
This commendation highly recognizes the labor-saving benefits and patient burden reduction innovations brought by "eclat" in the Japanese medical field, where shortages of healthcare professionals and work style reforms are urgent issues.
Background of the Award and Three Points of Evaluation for "eclat"
Even at the forefront of healthcare, "productivity improvement" accompanying "work style reform" is an important theme. At the 13th selection committee, our company's following achievements and social significance were recognized.
1. [Objective Achievement] Speed of adoption, with introduction to medical institutions nationwide approximately one year after launch.
Approximately one year after its sales launch (going to market) in November 2024, it has been introduced to numerous medical institutions nationwide, including university hospitals. This rapid adoption was evaluated as objective evidence that the product accurately captures and resolves the strong needs (challenges) that the medical field has been implicitly facing.
2. [Transformation from Conventional Testing] Reducing the burden on patients.
Conventional Holter electrocardiogram examinations imposed significant time and psychological burdens on patients due to the feeling of restraint from multiple electrode cords, restrictions on bathing, and the need for follow-up visits to return equipment. "eclat" is Japan's first disposable patch-type Holter electrocardiograph, which not only offers a cordless design but also focuses on reducing skin irritation, enabling 7 days of continuous monitoring without restricting patients' daily lives.
Equipment exchange is handled by mail, eliminating the need for patients to visit for equipment return, thereby reducing the burden on patients located far away. It fundamentally overturns the conventional approach to examinations, which were considered "difficult and troublesome," and contributes to improving patients' QOL (Quality of Life).
3. [Solving On-site Challenges] Labor savings and work style reform brought about by "complete disposability."
The "completely disposable" specification, the product's greatest feature, eliminates ancillary tasks for healthcare professionals such as equipment collection, cleaning, and disinfection after examinations. Furthermore, since no recharging is required for two years after manufacturing, there is no hassle of equipment maintenance or management, allowing for immediate testing when needed. Additionally, as interpretation by clinical laboratory technicians and cardiologists is included, in-house analysis work becomes unnecessary.
In Japan's medical field, where a declining working population and "physician work style reform" are urgent issues, this labor saving directly contributes to creating an environment where healthcare professionals can focus on their primary duties (dialogue with patients and diagnosis).
Product Overview: Completely Disposable Patch-Type Holter Electrocardiograph "eclat"
Japan's first 7-day continuous monitoring, completely disposable patch-type, no charging required for two years after manufacturing.
"eclat" is an electrocardiogram examination device that realizes Japan's first "completely disposable" specification. It dramatically reduces the burden on both patients and healthcare professionals by alleviating ancillary tasks in the medical field.
* Japan's first: As a "disposable Holter electrocardiograph that can be used continuously for 7 days" in Japan (as of the launch of "eclat" in November 2024, according to our company's research, including internet searches and medical device database surveys).
Main Features of "eclat"
1. Reduced operational burden with Japan's first "completely disposable" design.
No equipment collection, cleaning, or disinfection is required after examination. This contributes to reducing the risk of hospital-acquired infections and significantly reduces ancillary tasks for healthcare professionals.
2. "7-day continuous monitoring" that does not restrict patients' daily lives.
A compact, cordless patch-type design that eliminates the feeling of restraint from conventional multiple electrodes and cords. Patients can live their daily lives, including bathing and sleeping, while wearing it. As it is a disposable type, there is no waiting for equipment availability, and testing can start immediately. After the examination, simply return it by mail, eliminating the need for follow-up visits.
High-precision data collection is achieved while maintaining patients' QOL (Quality of Life).
3. "Maintenance-free" with no charging required for two years from manufacturing.
Thanks to its unique low-power design, it does not require recharging for two years after manufacturing and can be used immediately at any time. This eliminates the hassle of battery management and maintenance for medical institutions.
About the Furukawa Medical and Welfare Equipment Promotion Foundation's "Commendation"
The "Commendation and Research Grant," held annually by the Furukawa Medical and Welfare Equipment Promotion Foundation, is a prestigious system that officially honors individuals and organizations that contribute to life innovation in Japan's medical and welfare fields, and supports future research.
This system is broadly composed of two pillars: "Commendation" and "Research Grant." The "Commendation," for which our company was selected, is awarded to individuals and organizations that have already been put into practical use and have made clear contributions or achieved social results in areas such as architecture, equipment, devices, and systems in the medical and welfare fields.
Comment from Daiki Hayashi, Representative Director of Kokoromil Co., Ltd.
I am deeply grateful for receiving this honorable award. The rapid adoption of "eclat" is a result of the strong demand from the medical field for "reducing the burden on the workplace and patients." With this award as an impetus, we will continue to strive to solve social issues through the development of innovative devices that support Japan's medical infrastructure.
Company Overview
Kokoromil Co., Ltd. operates under the mission "Towards a society without regret due to illness," providing "Home Cardiac Dock®," which enables long-term examinations using wearable electrocardiographs. Through the data acquired, we aim to help many people visualize their own and their family's health status, thereby improving their healthy lifespan and QOL (Quality of Life).
Company Name: Kokoromil Co., Ltd.
Representative Director & President: Daiki Hayashi
Location: Kanno Building 2F, 6-2-16 Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-0023
Established: November 2021
Business Activities: Healthcare and clinical research business
HP: https://kokoromil.com/
[Contact for Inquiries]
Kokoromil Co., Ltd.
Public Relations Department: info@kokoromil.com
HP: https://kokoromil.com/
This commendation highly recognizes the labor-saving benefits and patient burden reduction innovations brought by "eclat" in the Japanese medical field, where shortages of healthcare professionals and work style reforms are urgent issues.
Background of the Award and Three Points of Evaluation for "eclat"
Even at the forefront of healthcare, "productivity improvement" accompanying "work style reform" is an important theme. At the 13th selection committee, our company's following achievements and social significance were recognized.
1. [Objective Achievement] Speed of adoption, with introduction to medical institutions nationwide approximately one year after launch.
Approximately one year after its sales launch (going to market) in November 2024, it has been introduced to numerous medical institutions nationwide, including university hospitals. This rapid adoption was evaluated as objective evidence that the product accurately captures and resolves the strong needs (challenges) that the medical field has been implicitly facing.
2. [Transformation from Conventional Testing] Reducing the burden on patients.
Conventional Holter electrocardiogram examinations imposed significant time and psychological burdens on patients due to the feeling of restraint from multiple electrode cords, restrictions on bathing, and the need for follow-up visits to return equipment. "eclat" is Japan's first disposable patch-type Holter electrocardiograph, which not only offers a cordless design but also focuses on reducing skin irritation, enabling 7 days of continuous monitoring without restricting patients' daily lives.
Equipment exchange is handled by mail, eliminating the need for patients to visit for equipment return, thereby reducing the burden on patients located far away. It fundamentally overturns the conventional approach to examinations, which were considered "difficult and troublesome," and contributes to improving patients' QOL (Quality of Life).
3. [Solving On-site Challenges] Labor savings and work style reform brought about by "complete disposability."
The "completely disposable" specification, the product's greatest feature, eliminates ancillary tasks for healthcare professionals such as equipment collection, cleaning, and disinfection after examinations. Furthermore, since no recharging is required for two years after manufacturing, there is no hassle of equipment maintenance or management, allowing for immediate testing when needed. Additionally, as interpretation by clinical laboratory technicians and cardiologists is included, in-house analysis work becomes unnecessary.
In Japan's medical field, where a declining working population and "physician work style reform" are urgent issues, this labor saving directly contributes to creating an environment where healthcare professionals can focus on their primary duties (dialogue with patients and diagnosis).
Product Overview: Completely Disposable Patch-Type Holter Electrocardiograph "eclat"
Japan's first 7-day continuous monitoring, completely disposable patch-type, no charging required for two years after manufacturing.
"eclat" is an electrocardiogram examination device that realizes Japan's first "completely disposable" specification. It dramatically reduces the burden on both patients and healthcare professionals by alleviating ancillary tasks in the medical field.
* Japan's first: As a "disposable Holter electrocardiograph that can be used continuously for 7 days" in Japan (as of the launch of "eclat" in November 2024, according to our company's research, including internet searches and medical device database surveys).
Main Features of "eclat"
1. Reduced operational burden with Japan's first "completely disposable" design.
No equipment collection, cleaning, or disinfection is required after examination. This contributes to reducing the risk of hospital-acquired infections and significantly reduces ancillary tasks for healthcare professionals.
2. "7-day continuous monitoring" that does not restrict patients' daily lives.
A compact, cordless patch-type design that eliminates the feeling of restraint from conventional multiple electrodes and cords. Patients can live their daily lives, including bathing and sleeping, while wearing it. As it is a disposable type, there is no waiting for equipment availability, and testing can start immediately. After the examination, simply return it by mail, eliminating the need for follow-up visits.
High-precision data collection is achieved while maintaining patients' QOL (Quality of Life).
3. "Maintenance-free" with no charging required for two years from manufacturing.
Thanks to its unique low-power design, it does not require recharging for two years after manufacturing and can be used immediately at any time. This eliminates the hassle of battery management and maintenance for medical institutions.
About the Furukawa Medical and Welfare Equipment Promotion Foundation's "Commendation"
The "Commendation and Research Grant," held annually by the Furukawa Medical and Welfare Equipment Promotion Foundation, is a prestigious system that officially honors individuals and organizations that contribute to life innovation in Japan's medical and welfare fields, and supports future research.
This system is broadly composed of two pillars: "Commendation" and "Research Grant." The "Commendation," for which our company was selected, is awarded to individuals and organizations that have already been put into practical use and have made clear contributions or achieved social results in areas such as architecture, equipment, devices, and systems in the medical and welfare fields.
Comment from Daiki Hayashi, Representative Director of Kokoromil Co., Ltd.
I am deeply grateful for receiving this honorable award. The rapid adoption of "eclat" is a result of the strong demand from the medical field for "reducing the burden on the workplace and patients." With this award as an impetus, we will continue to strive to solve social issues through the development of innovative devices that support Japan's medical infrastructure.
Company Overview
Kokoromil Co., Ltd. operates under the mission "Towards a society without regret due to illness," providing "Home Cardiac Dock®," which enables long-term examinations using wearable electrocardiographs. Through the data acquired, we aim to help many people visualize their own and their family's health status, thereby improving their healthy lifespan and QOL (Quality of Life).
Company Name: Kokoromil Co., Ltd.
Representative Director & President: Daiki Hayashi
Location: Kanno Building 2F, 6-2-16 Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-0023
Established: November 2021
Business Activities: Healthcare and clinical research business
HP: https://kokoromil.com/
[Contact for Inquiries]
Kokoromil Co., Ltd.
Public Relations Department: info@kokoromil.com
HP: https://kokoromil.com/